You are here

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Aurora, Colorado, 80045 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking Cessation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Have a diagnosis (using the SCID-I/P at screening visit) of schizophrenia or
schizoaffective disorder and judged to be stable (without hospitalization or acute
exacerbation and functioning in society) on psychiatric treatment for at least the
past 6 month.

- Current cigarette smokers (at least 15/day during the past year with no period of
abstinence greater than 3 months in the past year) male or female, between the ages of
18 and 75 inclusive, who are motivated to stop smoking.

- Score 7 or higher on the Contemplation Ladder at the Screening, Week -1, and Baseline
Visits.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- PANSS score >70 at Screen or Baseline Visit.

- Subjects hospitalized within the past six months due to suicidal ideation or suicidal
behavior or subjects considered to have serious suicidal ideation or suicidal behavior
within the past six moth.

- Subjects having active suicidal ideation or behavior identified at Screen, Week -1, or
Baseline Visit.

- Subjects taking Bupropion.

NCT00644969
Pfizer
Completed
Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now